Large order delays
MIGM and QRSAM orders may slip beyond March; management expects by Q1 FY27 at latest.
Apollo Micro Systems · risk themes across the available quarters.
Bear-case history
MIGM and QRSAM orders may slip beyond March; management expects by Q1 FY27 at latest.
IDL is currently loss-making; significant overhaul and capex needed, timeline uncertain.
Government may allow 100% foreign subsidiaries as Indian vendors, potentially increasing competition.
Receivables at ₹360 crore (close to Q1+Q2 revenue); management expects reduction by year-end.
The ₹2,500 crore order is pending DAC approval; any delay could impact revenue visibility.
IDL reported a loss of ₹4 crore in 45 days; management expects EBITDA breakeven only by Q4, with PAT positive from next year.
Resolution for corporate guarantees to subsidiaries was defeated by institutional shareholders, potentially impacting subsidiary support.
Material costs remain around 70% of revenue; improvement expected only when large-scale production orders kick in.